CA3092414C - Progastrine en tant que biomarqueur pour l'immunotherapie - Google Patents

Progastrine en tant que biomarqueur pour l'immunotherapie

Info

Publication number
CA3092414C
CA3092414C CA3092414A CA3092414A CA3092414C CA 3092414 C CA3092414 C CA 3092414C CA 3092414 A CA3092414 A CA 3092414A CA 3092414 A CA3092414 A CA 3092414A CA 3092414 C CA3092414 C CA 3092414C
Authority
CA
Canada
Prior art keywords
cdr
progastrin
amino acid
cancer
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3092414A
Other languages
English (en)
Other versions
CA3092414A1 (fr
Inventor
Dominique Joubert
Original Assignee
ECS Progastrin SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ECS Progastrin SA filed Critical ECS Progastrin SA
Priority claimed from PCT/EP2019/054878 external-priority patent/WO2019166499A1/fr
Publication of CA3092414A1 publication Critical patent/CA3092414A1/fr
Application granted granted Critical
Publication of CA3092414C publication Critical patent/CA3092414C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne des procédés de sélection de patients répondant à des inhibiteurs de points de contrôle immunitaires. L'invention concerne également des méthodes de traitement de patients cancéreux au moyen d'un inhibiteur de point de contrôle immunitaire.
CA3092414A 2018-02-27 2019-02-27 Progastrine en tant que biomarqueur pour l'immunotherapie Active CA3092414C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862635620P 2018-02-27 2018-02-27
US62/635,620 2018-02-27
PCT/EP2019/054878 WO2019166499A1 (fr) 2018-02-27 2019-02-27 Progastrine en tant que biomarqueur pour l'immunothérapie

Publications (2)

Publication Number Publication Date
CA3092414A1 CA3092414A1 (fr) 2019-09-06
CA3092414C true CA3092414C (fr) 2025-09-02

Family

ID=

Similar Documents

Publication Publication Date Title
US20220195035A1 (en) Monoclonal antibodies to progastrin and their uses
US8557964B2 (en) Anti CXCR4 antibodies and their use for the treatment of cancer
JP5749330B2 (ja) 癌を治療するためのヒト化抗ｃｘｃｒ４抗体
EA039377B1 (ru) Антитела к ceacam5 и их применения
CN102753580A (zh) 抗egfr抗体及其用途
US20190011447A1 (en) Compositions and methods for detecting and treating esophageal cancer
CN116249547B (zh) 脑特异性血管生成抑制剂1(bai1)抗体及其用途
AU2019228339B2 (en) Progastrin as a biomarker for immunotherapy
US20250043016A1 (en) Tnfr2 binding molecule and use thereof
AU2014203017B2 (en) Monoclonal antibodies to progastrin and their uses
US20190194319A1 (en) Anti-ascl1 antibodies and methods of use
WO2024251051A1 (fr) Polythérapies impliquant des antagonistes de claudine 18.2 pour le traitement du cancer
HK40002657A (en) Monoclonal antibodies to progastrin and their uses